The effects of monoclonal antibodies (mAbs) to cell-surface molecules, divalent , and 0TCR (R73) stimulated the adhesion via an LFA-1-dependent pathway, whereas an anti-CD45 mAb (G3C5) stimulated the rosette formation independently of LFA-1. MAbs to CD2 (OX-34), CD11b (ED7), CD11b/c (OX-42), and class MHC (OX-18) were without significant effects on the adhesion process.
INTRODUCTION
Thymic dendritic cells (TDC) represent minor, but functionally very significant component of the thymic microenvironment (Hamblin and Edgeworth, 1988) . They are derived from the bone marrow and selectively colonize cortico-medullary region and medulla (Barclay and Mayrhofer, 1981; Duijvestijn et al., 1984; Kampinga and Aspinal 1990) . TDC are believed to participate in the maturational process of thymocyte development (Kyewski, 1988) , intrathymic presentation of nonmajor histocompatibility complex (non-MHC) antigens (Kyewski et al., 1986) , clonal deletion of autoreactive thymocytes (Carlow et al., 1992) , or clonal amplification of mature medullary thymocytes (Landry et al., 1990) . However, how they influence these intrathymic events is still being debated.
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Enzyme digestion of thymic stroma enables isolation of different complexes composed of nonlymphoid cells and thymocytes (Kyewski et al., 1982) . TDC are also rosette-forming cells (Kyewski et al., 1982; Landry et al., 1990; Shortman and Vremec, 1991) . It is postulated that these close cell-cell contacts are responsible for most of TDC functions (Adkins et al., 1986; Kyewski, 1988) . Although interactions between peripheral dendritic cells (DC) and T lymphocytes have been extensively explored, little is known about the mechanisms involved in TDC/thymocyte binding. This question is addressed in the present work using an original system for isolation of rat TDC.
RESULTS
Dynamics of Thymocyte Adhesion to Rat TDC To study adhesion characteristics of rat TDC, we first used an alternative method for their isolation and 37 purification (Ilid et al., in press ). This included isolation of low-density cells from thymocyte suspension over a Nycodenz gradient (density 1.078 g/cm3; osmolarity 390 mOsm) and their subsequent cultivation with 20% TE-R 2.5 + HT supernatant obtained by cocultivation of a medullary epithelial cell line (TE-R 2.5) (olid et al., 1992) A lot of mAbs stimulated TDC/thymocyte binding. They were OX-3 and OX-6 (both directed to class II MHC molecules), R73 (anti-0[3TCR), W3/25 (anti-CD4), , and G3C5 (anti-CD45 framework) antibody (Fig. 9 ). The gtimulated adhesion was not only manifested by an increase in the percentage of rosettes, but also by a significant enlargement of their sizes.
The stimulatory effect of anti-0[3TCR, anti-CD4, and anti-CD8 was visible during the first adhesion phase (30 min), whereas the effect of OX-3 and OX-6 mAbs was observed after 3 hr of cell incubation.
G3C5 mAb stimulated TDC/thymocyte binding in both adhesion phases. OX-18 mAb, directed to class I MHC, was without significant effect in this process. We further tested whether stimulatory effects of these mAbs were mediated by LFA-1. The results presented in Fig. 9 Springer, 1990) .
Significance of the LFA-1/ICAM-1 pathway in thymocyte maturation is well documented because mAbs to these molecules block the development of DP thymocytes in fetal thymic organ culture (Fine and Kruisbeek, 1991) and antigen-dependent deletion of DP thymocytes from mice that are transgenic for class I MHC-restricted TCRs (Carlow et al., 1992; Pircher et al., 1993) . The latter findings are of special interest because TDC are believed to play a crucial role in negative selection (deletion of autoreactive T cells in the thymus) (Ramsdell and Fowlkes, 1990) .
We demonstrated that TDC/thymocyte binding was not completely blocked by anti-LFA-1, anti-CD18, and anti-ICAM-1 mAbs, suggesting that other adhesion molecules are involved.
MAbs against CD11b were not inhibitory, which is in contrast with their effect on clustering between peripheral rat DC and T lymphocytes (Damoiseaux, 1991) or thymocytes and thymic macrophages (M) (olid et al., 1994) . One possible explanation of the phenomenon is a low expression of this [2 integrin on TDC (Ili et al., in press). Scheeren et al. (1991) also reported that adhesion between peripheral DC and T cells was partly LFA-l-independent because T cells from leukocyte adhesion deficiency (LAD), which are defective in ]2 integrin expression, bound to DC at low rates. We did not identify other adhesion molecules because numerous mAbs against different surface-cell molecules were not inhibitory. It was important to stress that OX-34 (anti-CD2) mAb used in this study as well as other anti-CD2 mAbs (OX-54 and OX-55) (data not shown) did not inhibit rosette formation, suggesting that the CD2/CD48 interaction (Killen et al., 1988) was not probably operative under these experimental conditions. It was demonstrated that the CD2/LFA-3 pathway is not involved in T-cell/blood-DC (Scheeren et al., 1991) binding, which is in contrast to the situation of T-cell adhesion to tonsillar DC, where this path-THYMIC DENDRITIC CELL/THYMOCYTE ADHESION 47 way has been found to play a role (King and Katz, 1989) .
A number of adhesion molecules has been identified on DC such as B7, B7-2, VCAM-1, CD44 (King and Katz, 1989; Scheeren et al., 1991; Caux et al., 1994; Inaba et al., 1994) , but their role in binding of thymocytes to TDC has not been studied. We found that mAbs against CD4, CD8, {x3TCR, and class II MHC molecules stimulated TDC / thymocyte adhesion. The process was probably not a consequence of a simple crosslinking of mAbs on cell surface because the stimulated adhesion was not seen at 4C
(not shown) and was inhibited by (Fig. 9) (Fig. 8) or anti-CD43 and OX-52 (not shown), were not stimulatory. This is another argument favoring the specificity of the observed phenomenon.
The stimulated adhesion could be explained by previous results that showed that signaling through TCR and coreceptor molecule triggered by specific mAbs to these antigens increased affinity of LFA-1 for its ligand van Kooyk et al., 1989) . The effect was not a consequence of the upregulation of the LFA-1 expression on cell surface, but rather was a result of conformational changes of the LFA-1 molecule. A similar effect of mAbs to CD3, CD4, and CD8 was observed in another system of heterotypic cell adhesion using thymocytes and thymic epithelial cell lines (Lepesant et al., 1990) . Certain mAb to class II MHC induced homotypic aggregation of lymphocytes that was also partly LFA-l-dependent (Kansas and Tedder, 1991) .
Our preliminary results showed that all these stimulatory antibodies modify intracellular signaling pathways of thymocytes, but their effects on thymocyte proliferation in the presence of TDC are not the same. Namely, R73 stimulated thymocyte proliferation, whereas the others were inhibitory. The results are in agreement with those reported by Xu et al. (1992) , who did not show the correlation between the intensity of human blood DC/T lymphocyte clustering and proliferation rates of the T cells.
In contrast to the previous mAbs, an anti-CD45 framework mAb (G3C5) stimulated the adhesion via an LFA-l-independent pathway. This antibody, which has been recently produced in our laboratory (Pavlovid et al., manuscript in preparation), induces strong homotyipic aggregation of rat leukocytes. It was also found that certain anti-human CD45 mAbs either increased the size of clusters in culture of DC and human T lymphocytes (Xu et al., 1992) as well as tonsillar T cells and U-937 cells (King et al., 1990) or reduced cluster stability between DC and T lymphocytes (Prickett and Hart, 1990) . G3C5 is different from similar proaggregatory anti-CD45 mAbs (Lorenz et al., 1993; Bernard et al., 1994) by its capability to induce the LFA-l-independent adhesion of both resting and activated leukocytes and at the same time to stimulate mitogen-induced Tlymphocyte proliferation and allogeneic MLR. The effect is probably epitop-specific and is not influenced by isotype of the mAb (IgM) (Pavlovid et Our results showed that an intact cytoskeleton and the activity of calmodulin-dependent protein kinase were partly responsible for TDC/thymocyte adhesion because the process was blocked by cytochalasin B and W7, respectively. This is in agreement with the results published for blood DC/T-cell binding (Scheeren et al., 1991) . We hypothesize that W7 inhibits cell adhesion by modulating cytoskeleton integrity, because similar observations were published in our recent study dealing with the LFA-1-dependent homotypic aggregation of rat leukocytes .
Blood DC/T-cell adhesion was also partly blocked by H7 (an inhibitor of PKA and PKC) (Scheeren et al., 1991) (Table 2 ). G3C5 (anti-CD45 framework) (IgM) (Pavlovid et al., manuscript in preparation) was produced at the Institute of Medical Research (MMA, Belgrade). Mabs WT.1 (anti-CD11a; IgG2a), WT.3 (anti-CD18; IgG1; Tamatani et al., 1991a) and 1A29 (anti ICAM-1; IgG1; Tamatani and Miyasaka 1990) were produced in Tokyo. All these mAbs recognize "inhibitory" epitopes on the corresponding molecules (Tamatani et al., 1991b) . ED7 mAb (IgG1) reactive with rat CD11b (Damoiseaux et al., 1989 ) was a gift from Dr. C. Dijkstra (Amsterdam) and R73 (anti-013TCR; IgG1; Hunig et al., 1989) (Tamatani and Miyasaka, 1990) and (Tamatani et al., 1991a) b. D. mAb obtained from Dr. C. Dijkstra, Amsterdam (Damoiseaux et al., 1989) . E. mAb obtained from Dr. T. Hunig (Wurzburg) (Hunig et al., 1989 
